Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis. A Misdiagnosis or Free-Living Amoeba Acting as Trojan Horse?
SVOA Neurology · 2021
DOI: 10.58624/svoane.2022.02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift SVOA Neurology, 2021. Verfasst von Rolando Lovaton.
Abstract (Originalsprache)
Amebic encephalitis is a rare and devastating disease.Mortality rate is almost 90% of cases.Here is described a very rare case of bacterial brain abscess in a patient with recent diagnosis of granulomatous amebic encephalitis.Case Description: A 29-year-old woman presented with headache, right hemiparesis and tonic-clonic seizure.Patient was diagnosed with granulomatous amebic encephalitis due to Acanthamoeba spp.; although, there was no improvement of symptoms in spite of stablished treatment.Three months after initial diagnosis, a brain MRI showed a ring-enhancing lesion in the left frontal lobe compatible with brain abscess.Patient was scheduled for surgical evacuation and brain abscess was confirmed intraoperatively.However, Gram staining of the purulent content showed gram-positive cocci.Patient improved headache and focal deficit after surgery.Conclusion: It is the first reported case of a patient with central nervous system infection secondary to Acanthamoeba spp.who presented a bacterial brain abscess in a short time.
Zitieren
APA
Lovaton, R. (2021). Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis. A Misdiagnosis or Free-Living Amoeba Acting as Trojan Horse?. SVOA Neurology. https://doi.org/10.58624/svoane.2022.02.026
Vancouver
Lovaton R. Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis. A Misdiagnosis or Free-Living Amoeba Acting as Trojan Horse?. SVOA Neurology. 2021. doi:10.58624/svoane.2022.02.026
BibTeX
@article{Lovaton2021,
author = {Lovaton, Rolando},
title = {Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis. A Misdiagnosis or Free-Living Amoeba Acting as Trojan Horse?},
journal = {SVOA Neurology},
year = {2021},
doi = {10.58624/svoane.2022.02.026}
}
EUVIMED